Click chemistry-assisted synthesis of triazolo linked podophyllotoxin conjugates as tubulin polymerization inhibitors

被引:17
作者
Vishnuvardhan, M. V. P. S. [1 ]
Reddy, Saidi V. [1 ]
Chandrasekhar, Kunta [1 ]
Nayak, V. Lakshma [1 ]
Bin Sayeed, Ibrahim [1 ]
Alarifi, Abdullah [2 ]
Kamal, Ahmed [1 ,2 ]
机构
[1] CSIR Indian Inst Chem Technol, Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India
[2] King Saud Univ, Coll Sci, Dept Chem, Catalyt Chem Res Chair, Riyadh 11451, Saudi Arabia
关键词
TOPOISOMERASE-II INHIBITORS; APOPTOSIS INDUCING AGENTS; BIOLOGICAL EVALUATION; ANTITUMOR AGENTS; 4-BETA-AMINOPODOPHYLLOTOXIN CONGENERS; ANTIMITOTIC AGENTS; ANTICANCER AGENTS; ONE-POT; DNA; ETOPOSIDE;
D O I
10.1039/c7md00273d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new triazolo linked 4 beta-amidopodophyllotoxin conjugates (9a-l) were synthesized using click chemistry and evaluated for their antitumor activity against four human cancer cell lines. Among them, two compounds (9c and 9j) showed significant anticancer activity with IC50 values of 0.9 and 0.07 mu M, respectively. Biological studies are conducted into the cell-cycle distribution of these conjugates inducing G2/Mphase arrest, apart from an increase in the levels of caspase-3 proteins, followed by apoptotic cell death. A tubulin polymerization assay analysis showed that these compounds effectively inhibit microtubule assembly in HeLa cells and, moreover, Hoechst 33258 and Immunohistochemistry staining suggest that these compounds induce cell death by apoptosis. The docking studies showed that compounds 9c and 9j interact and bind efficiently with the tubulin protein at the colchicine site.
引用
收藏
页码:1817 / 1823
页数:7
相关论文
共 42 条
  • [1] FADROZOLE HYDROCHLORIDE - A POTENT, SELECTIVE, NONSTEROIDAL INHIBITOR OF AROMATASE FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISEASE
    BROWNE, LJ
    GUDE, C
    RODRIGUEZ, H
    STEELE, RE
    BHATNAGER, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) : 725 - 736
  • [2] Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
    Burden, DA
    Osheroff, N
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 139 - 154
  • [3] Caner B. A., 1996, Cancer therapy and biotherapy
  • [4] Chang J. Y., 1991, CANCER RES, V51, P195
  • [5] Antitumor agents .163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q(2)-GRS approach
    Cho, SJ
    Tropsha, A
    Suffness, M
    Cheng, YC
    Lee, KH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (07) : 1383 - 1395
  • [6] Structural insight into the inhibition of tubulin by vinca domain peptide ligands
    Cormier, Anthony
    Marchand, Matthieu
    Ravelli, Raimond B. G.
    Knossow, Marcel
    Gigant, Benoit
    [J]. EMBO REPORTS, 2008, 9 (11) : 1101 - 1106
  • [7] Dassault Systemes BIOVIA, 2016, DS VIS CLIENT V16 1
  • [8] Desbene Stephanie, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P71, DOI 10.2174/1568011023354353
  • [9] Donald T. L. Mac, 1991, DNA TOPOISOMERASES C, P119
  • [10] Etoposide: Four decades of development of a topoisomerase II inhibitor
    Hande, KR
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) : 1514 - 1521